Background
Caffeine has been associated with enhancing the ability to perform mental tasks and elevate feelings of energy, however, a single dose of caffeine typically induces only 90-120 minutes of increased alertness and is often associated with an acute “crash” state following its metabolism. The nature of formulation can directly influence the rate and extent of absorption following oral administration. Time-release caffeine supplements have been developed to prolong the effects of caffeine. The purpose of this study was to compare the plasma caffeine pharmacokinetics following ingestion of a time-release caffeine capsule (TR-CAF) to an equivalent dose of a regular caffeine capsule (CAF) and a placebo (PL) over an 8-hour period.
Methods
Ten healthy males (25.9 ± 3.2 y; 181.3 ± 8.2 cm; 92.9 ± 9.9 kg; 13.3 ± 3.6 % body fat) who regularly consume caffeine volunteered to participate in this double-blind, placebo-controlled, cross-over study. Participants were randomized into three experimental trials: Ingestion of EnergizeTM; CAF; and PL. The EnergizeTM supplement contained 194 mg time-release caffeine and CAF contained the equivalent amount of regular caffeine. PL contained rice flour only. Blood draws occurred at baseline and at every hour during the 8-hour period. Participants were provided a standardized breakfast and lunch and were permitted to drink water ad libitum. Plasma caffeine concentrations were quantified using high performance liquid chromatography (HPLC). Consent to publish the results was obtained from all participants.
Anzeige
Results
Plasma caffeine concentrations for both caffeine supplements were significantly greater than PL over the 8-hour study duration. CAF rapidly reached peak plasma caffeine concentration (2.40 ± 0.40 mg•L-1) at 3 hours following ingestion, while TR-CAF reached peak plasma caffeine concentration (1.88 ± 0.46 mg•L-1) at 6 hours following ingestion. Plasma caffeine concentrations were significantly greater (p<0.05) in CAF compared to TR-CAF during hours 2-5. However, plasma caffeine concentrations were significantly greater (p=0.042) in TR-CAF compared to CAF at hour 8. AUC analysis showed plasma caffeine concentrations for CAF were significantly greater than TR-CAF for hours 1-4 (p<0.0001) and over the 8-hour study duration (p<0.001).
Conclusion
The results suggest that the rate of caffeine absorption following TR-CAF was slower and more sustained as compared to CAF over 8 hours following ingestion which may prolong the effects of caffeine and limit the acute “crash” state.
Acknowledgements
This study was funded through a grant from iSatori, Inc., Golden, CO, USA.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.